Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Stan Baker

Set Alert for Articles By Stan Baker

Latest From Stan Baker

Antibiotic resistance, politics and diagnostic investment opportunities

On March 2, 2015, California’s Senator Feinstein reintroduced a bill first submitted in 2013 titled 'Preventing Antibiotic Resistance Act of 2015'. In just nine double-spaced pages the bill, if enacted in its current form, will drastically change how antibiotics are developed and used in production animals in the US. Dr Stan Baker, a lawyer with Husch-Blackwell, investigates the impact of the legislation.

Pharmaceuticals Diagnostics

Review 2014: Animal health investment is both hot and cold

With respect to keeping 'chatter' about animal health investment alive, Zoetis is the gift that keeps on giving.

Policy & Regulation Pain

Animal health investments: 'The Secret Drawer'

Last week, Kansas City hosted the Animal Health Corridor Investment Forum. This is the first Forum following the explosive emergence of animal health as a Wall Street phenomenon.

Veterinary pharmaceutical compounding: A possible path to answers?

Three words: 'Veterinary pharmaceutical compounding'. Undoubtedly these words would likely increase the blood pressure of some Animal Pharm readers.

Pharmaceuticals Policy & Regulation

Animal health IPOs risk investment bubble

Initial public offerings (IPOs) are all the rage in the animal health industry because they are new, sexy, and unknown, much like a beautiful stranger you might meet at a cafe in Paris. And just as with the stranger in Paris, the infatuation investors have for animal health could lead to happiness or it could lead to disaster. 

Aratana Therapeutics Kindred Biosciences

Antitrust, trade secrets and regulatory issues in animal health

Why does the veterinary products industry need dedicated lawyers? Husch Blackwell's Stan Baker explains his role within the US law firm as part of the animal health team.

Policy & Regulation Zoetis
See All